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Introduction
In organ transplantation are well-established strategies to maintain morphological aspects and graft function. These strategies include hemodynamic stability of donor, previous health status, absence of diseases. In addition, interventions at the time of the donor operation, such as hypothermia, preservation solution and use of substances, may modulate or ischemic and/or reperfusion injury.
The success of organ transplantation depends on, in part, how it has been preserved. The form of preservation is essential to ensure the viability of the graft during storage, and will determine its functioning post-transplantation. One of the strategies used in organ transplants to minimize the injury caused by ischemia is hypothermia. It decreases the cellular components degradation, which is essential for cell viability, enzymatic reactions speed and cell death occurrence, also prevents intracellular acidosis [1] [2] [3] . This cold-induced down regulation of the metabolism protects the graft against reactive species of oxygen, during reperfusion 2, 4 .
The ischemia occurs when there is a reduction or interruption of blood flow, leading to oxygen deprivation, activation anaerobic metabolism to obtain energy and inducing imbalance of electrolyte homeostasis, cellular dysfunction, cellular and interstitial edema, intense formation of free radicals and, posteriorly, cell death by necrosis and/or apoptosis 5, 6 .
The use of antioxidants has been proposed as pharmacological strategy to modulate ischemia and reperfusion injury (I/R) injury. The antioxidant is used to decrease reactive oxygen species production during I/R process 7-9 .
The glutathione is an endogenous antioxidant, donating electrons to neutralize and removing free radicals.
N-acetylcysteine, which is a thiol precursor of glutathione, is an exogenous antioxidant used to induce elevation of hepatic glutathione. Previous studies have shown that N-acetylcysteine attenuated I/R injury on liver and intestine in normothermic conditions 7, 9, 10 . In experimental hepatic ischemic injury, the treatment with the N-acetylcysteine, immediately before ischemia, preserved morphological architecture and tissue functionality during ischemia [8] [9] [10] . However, its effect on hypothermic liver preservation has not been studied.
The aim of this study was evaluate the effect of N-acetylcysteine on hepatic histomorphology during different intervals of hypothermic preservation. and N-acetylcysteine (NAC, n=6).
Methods

Adult male
Experimental design
All rats were anesthetized intramuscularly with a solution of ketamine (60mg/kg) and xylazine (10mg/kg) and received intravenous doses of heparin (100U/100g). A median laparotomy was performed to exposed abdominal aorta and vena cava and administration of saline or NAC (150 mg/kg). After 15 minutes, abdominal aorta was catheterized to Ringer lactate (4°C) perfusion (10 minutes); vena cava was used to blood and perfusion solution drainage, and liver was collected to 24h preservation study 18 .
During the period of preservation, the liver was 
Statistical analysis
For data analysis, it was used the statistical software 
Results
The values among different time-points showed progressive injury, increasing occurrence of apoptotic hepatocyte in both groups (Figure 1 ). In the Control group, the values at the T24 were significantly higher (p<0.05) compared to each other time-point. However, in the NAC group, the T24 values were similar to the T12 and T18, and all of them were different from the T0 values (p<0.05). N-acetylcysteine pretreatment showed important initial reduction of apoptotic hepatocyte (T0=4%) compared to the control group (T0=6%; p<0.05).
N-acetylcysteine treatment attenuated the preservation hepatic injury only in the time-point T0, maintaining the tissue architecture and absence of edema compared to control (Figure 2 ).
In the time-point T24, both group showed alterations in the hepatic tissue architecture, but the NAC group showed just a slight tissue injury ( Figure 3) . In both groups, vacuolization occurred after 12h of cold preservation. 
Discussion
The present study showed reduction of apoptosis occurrence in the early phase of liver hypothermic preservation when administered N-acetylcysteine. This effect did not persist during other periods of observation in the study protocol.
The ischemia caused when there is an interruption of the blood supply is well known and the strategies used to minimize this type of injury has been studied. N-acetylcysteine, an antioxidant, has shown beneficial effect on injury I/R in the microcirculation and reducing of the interaction between leukocytes and endothelium, but no effect on the activity of cells Kupffer 12 .
N-acetylcysteine in the liver provides protection by inducing increased hepatic glutathione and retain the enzymatic function.
Aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase and total bilirubin are function liver markers, providing information on liver injury. Studies show that the treatment with N-acetylcysteine reduces these markers and decrease the injury I/R 3, 6 .
A methodology using light microscopy with hematoxylin and eosin-stained sections has been applied to identify anoikis, nuclear and cytoplasmic condensation, and apoptotic bodies 13, 14 . The apoptotic index used in this study followed the nuclei and cytoplasm morphological characteristics of hepatocyte apoptosis [14] [15] [16] and results showed significant changes during follow-up. In view of the effects of N-acetylcysteine on the apoptotic index of liver subjected to hypothermic preservation hepatocytes, the future prospect of this study is to confirm the apoptosis by immunohistochemical marking, for example, anticaspase 3 cleaved antibody or TUNEL.
Results of the administration of N-acetylcysteine in this study corroborate the microscopic features reported in previous studies, showing that N-acetylcysteine reduces significantly the degree of hepatic congestion 17 and preserves parenchimal 3 .
However, studies should proceed with reperfusion of the organ to verify more adequately the effect of NAC on liver parenchyma.
Conclusion
Hypothermic preservation, over time, causes changes in the hepatic parenchyma with increased apoptosis, loss of architecture, vacuolization, culminating in severe injury. The administration of N-acetylcysteine protects against preservation liver injury.
